{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T06:05:52Z","timestamp":1775628352307,"version":"3.50.1"},"reference-count":27,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Respir Care"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>There are several tests recommended by the American Thoracic Society (ATS) to evaluate for airway hyper-responsiveness (AHR), one of which is methacholine challenge testing (MCT). Few studies have examined the correlation of baseline spirometry to predict AHR in MCT, especially in the younger, relatively healthy military population under clinical evaluation for symptoms of exertional dyspnea. The study aim was to retrospectively correlate baseline spirometry values with MCT responsiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This study is a retrospective review of all MCT performed at Brooke Army Medical Center\/Wilford Hall Medical Center over a 12-y period; all completed studies were obtained from electronic databases. The following parameters were analyzed from the studies: baseline FEV\n                      <jats:sub>1<\/jats:sub>\n                      , FVC, FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/FVC, mid-expiratory flow (FEV\n                      <jats:sub>25-75%<\/jats:sub>\n                      ), FEV\n                      <jats:sub>25\u201375%<\/jats:sub>\n                      \/FVC. Studies were categorized based on baseline obstruction, restriction, FEF\n                      <jats:sub>25\u201375%<\/jats:sub>\n                      lower limit of normal, and response to bronchodilator testing (if completed); these values were compared based on methacholine reactivity and severity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Methacholine challenge studies (\n                      <jats:italic toggle=\"yes\">n =<\/jats:italic>\n                      1,933) were reviewed and categorized into reactive (\n                      <jats:italic toggle=\"yes\">n =<\/jats:italic>\n                      577) and nonreactive (\n                      <jats:italic toggle=\"yes\">n =<\/jats:italic>\n                      1,356) as determined by ATS guidelines. The mean baseline FEV\n                      <jats:sub>1<\/jats:sub>\n                      (% predicted) with MCT reactivity was 88.0 \u00b1 13.0% versus no MCT reactivity was 92.7 \u00b1 13.0% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). The mean baseline FVC (% predicted) was 93.1 \u00b1 13.7% versus 95.3 \u00b1 13.5% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). The mean baseline FEV\n                      <jats:sub>25\u201375%<\/jats:sub>\n                      (% predicted) was 80.0 \u00b1 22.1% versus 89.0 \u00b1 23.4% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Based on partition analysis, methacholine reactivity was most prevalent with baseline obstruction,\n                      <jats:italic toggle=\"yes\">n =<\/jats:italic>\n                      115 (43%), and in the absence of obstruction, when the FEF\n                      <jats:sub>25\u201375%<\/jats:sub>\n                      (% predicted) was below 0.70,\n                      <jats:italic toggle=\"yes\">n =<\/jats:italic>\n                      111 (40%). The negative predictive value with normal spirometry was 73%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      The analysis of baseline spirometry prior to MCT proved useful in the evaluation of exertional dyspnea in a military population. The presence of airways obstruction (FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/FVC &lt; lower limit of the normal range) followed by a reduction in FEV\n                      <jats:sub>25\u201375%<\/jats:sub>\n                      &lt; 70% predicted showed a positive correlation with underlying AHR. In patients with exertional dyspnea and normal baseline spirometry, the use of the FEF\n                      <jats:sub>25\u201375%<\/jats:sub>\n                      may be a useful surrogate measurement to predict reactivity during MCT and consideration for additional testing or treatment\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4187\/respcare.09163","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T14:45:52Z","timestamp":1642517152000},"page":"694-701","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Baseline Spirometry as a Predictor of Positive Methacholine Challenge Testing for Exertional Dyspnea"],"prefix":"10.1177","volume":"67","author":[{"given":"John C","family":"Hunninghake","sequence":"first","affiliation":[{"name":"Pulmonary\/Critical Care Service, Department of Medicine, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah B","family":"McCullough","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K","family":"Aden","sequence":"additional","affiliation":[{"name":"Graduate Medical Education, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie A","family":"Hayes","sequence":"additional","affiliation":[{"name":"Pulmonary\/Critical Care Service, Department of Medicine, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T","family":"McCann","sequence":"additional","affiliation":[{"name":"Pulmonary\/Critical Care Service, Department of Medicine, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Morris","sequence":"additional","affiliation":[{"name":"Pulmonary\/Critical Care Service, Department of Medicine, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"issue":"1","key":"e_1_3_2_2_2","first-page":"309","article-title":"Guidelines for methacholine and exercise challenge testing-1999","volume":"161","author":"American Thoracic Society","year":"1999","unstructured":"American Thoracic Society. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med, 19992000;161(1):309-329.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"e_1_3_2_3_2","first-page":"265","article-title":"Bronchial challenge testing","volume":"1","author":"Irvin CG","year":"1995","unstructured":"Irvin CG. Bronchial challenge testing. Respir Care Clin N Am, 1995; 1(2):265-285.","journal-title":"Respir Care Clin N Am"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.3.742"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/167.4.281"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1081\/JAS-120037656"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.3.701"},{"key":"e_1_3_2_8_2","volume-title":"Standards of Medical Fitness","author":"Army Regulation 40\u2013501","year":"2016","unstructured":"Army Regulation 40\u2013501. Standards of Medical Fitness. Washington, District of Columbia: Headquarters, Department of the Army; 2 2 D e c 2016."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.3.661"},{"issue":"2","key":"e_1_3_2_10_2","first-page":"47","article-title":"The association between baseline lung function and bronchial responsiveness to methacholine","volume":"2","author":"Wassmer G","year":"1997","unstructured":"Wassmer G, , Jorres RA, , Heinrich J, , Wjst M, , Reitmeir P, , Wichmann HE. The association between baseline lung function and bronchial responsiveness to methacholine. Eur J Med Res, 1997; 2(2):47-54.","journal-title":"Eur J Med Res"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-131"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.20631"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.1.9712108"},{"key":"e_1_3_2_14_2","volume-title":"Multiple comparisons and multiple tests using SAS","author":"Westfall PH","year":"2011","unstructured":"Westfall PH, , Tobias RD, , Wolfinger RD. Multiple comparisons and multiple tests using SAS, 2nd ed.. Cary, North Carolina: SAS Institute; 2011.","edition":"2"},{"issue":"3","key":"e_1_3_2_15_2","first-page":"221","article-title":"The FEF25-75% and the clinical diagnosis of asthma","volume":"199473","author":"Alberts WM","unstructured":"Alberts WM, , Ferris MC, , Brooks SM, , Goldman AL. The FEF25-75% and the clinical diagnosis of asthma. Ann Allergy, 199473(3):221-225.","journal-title":"Ann Allergy"},{"issue":"2","key":"e_1_3_2_16_2","first-page":"90","article-title":"Forced expiratory flow at 25\u201375% as a marker for airway hyper-responsiveness in adult patients with asthma-like symptoms","volume":"17","author":"Raji H","year":"2018","unstructured":"Raji H, , Shoushtari MH, , Idani E, , Tavakol H, , Afrakhteh S, , Dastoorpoor M, , Borsi SH. Forced expiratory flow at 25\u201375% as a marker for airway hyper-responsiveness in adult patients with asthma-like symptoms. Tanaffos, 2018; 17(2):90-95.","journal-title":"Tanaffos"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED.172.11.1194"},{"issue":"3","key":"e_1_3_2_18_2","first-page":"239","article-title":"Underdiagnosis of asthma in young adults presenting for USAF basic training","volume":"69","author":"Nish WA","year":"1992","unstructured":"Nish WA, , Schwietz LA. Underdiagnosis of asthma in young adults presenting for USAF basic training. Ann Allergy, 1992; 69(3):239-242.","journal-title":"Ann Allergy"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.102.2.347"},{"issue":"6","key":"e_1_3_2_20_2","first-page":"783","article-title":"Maximal mid-expiratory flow rate","volume":"72","author":"Leuallen EC","year":"1955","unstructured":"Leuallen EC, , Fowler WS. Maximal mid-expiratory flow rate. Am Rev Tubercul, 1955; 72(6):783-790.","journal-title":"Am Rev Tubercul"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2006.27.2903"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.5.9803063"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.63"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/02770900802492079"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000443797"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2012.33.3524"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/03946320110240S404"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145476"}],"container-title":["Respiratory Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.4187\/respcare.09163","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4187\/respcare.09163","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4187\/respcare.09163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:27:24Z","timestamp":1775626044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4187\/respcare.09163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.4187\/respcare.09163"],"URL":"https:\/\/doi.org\/10.4187\/respcare.09163","relation":{},"ISSN":["0020-1324"],"issn-type":[{"value":"0020-1324","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,18]]}}}